Abstract. Blood 
newly diagnosed insulin-dependent diabetic (IDDM) patients treated with insulin for 5 \p=n-\7days were assessed for the number of spontaneous and pokeweed mitogen (PWM)-stimulated immunoglobulin-secreting cells in a reverse haemolytic plaque assay. The spontaneous in vitro immunoglobulin secretion was evanescent and decreased in individual patients within 1\p=n-\4months of insulin treatment. Compared to matched controls, 53% (9/17) of the IDDM patients had an elevated spontaneous secretion of immunoglobulin, 41% (7/17) for IgG, 35% (6/17) for IgM, and 35% (6/17) for IgA. The quantities of PWM-stimulated IgG, IgM, or IgA secreting cells in IDDM were comparable to the controls. The IDDM patients with spontaneous immunoglobulin secreting cells had higher fasting C-peptide levels compared to the patients with immunoglobulin-producing cells within the normal range (P < 0.05). The average titre of islet cell cytoplasmic antibodies was 1:26 in (9 out of 9 were positive) patients with, compared to 1:1 in patients (4 out of 8 were positive) without spontaneous secretion (P = 0.025). These results suggest that the clinical onset of IDDM is associated with a polyclonal B lymphocyte activation and that higher levels of fasting C-peptide islet cell antibodies are associated with this immunoregulatory abnormality.
Insulin-dependent diabetes mellitus (IDDM) in young individuals is associated with a high inci¬ dence of circulating antibodies reacting not only with pancreatic islet cells (Bottazzo et al. 1974; Irvine et al. 1977; Lernmark et al. 1978; Dobersen et al. 1980 ) but also with other endocrine cells (MacCuish & Irvine 1975; Nerup & Lernmark 1981) , non-endocrine cells (Serjeantson et al. 1981) or subcellular constituents such as single-stranded DNA and double-stranded RNA (Huang et al. 1981 ). The prevalence of islet cell antibodies has been found to be highest close to the diagnosis of the disease with a decline thereafter. Furthermore, increased levels of la antigen bearing lympho¬ cytes have been noted in the blood of newly diag¬ nosed IDDM patients (Jackson et al. 1982) . Al¬ though controversial (Jackson et al. 1982; MascartLemone et al. 1982) , such patients often exhibit a decrease in the number of OKT8 (cytotoxic/ suppressor cells) reactive peripheral lymphocytes (Galluzzo et al. 1982; Buschard et al. 1983; Horita et al. 1982) and a depressed suppressor cell activity (Buschard et al. 1980; Fairchild et al. 1982) . These abnormalities in cell-mediated immunity appeared transient as they could not be detected 2-6 months after the clinical onset of IDDM (Buschard et al. 1980 (Buschard et al. , 1983 Horita et al. 1982; Fairchild et al. 1982 
Assays for organ-specific antibodies
The patients' sera were checked for anti-cytoplasmic islet cell antibodies by the indirect immunofluorescence method as described by Marner et al. (1983) Circulating fasting plasma C-peptide was determined by radioimmunoassay (Binder & Faber 1978 (Ptak et al. 1980 ). It has also been shown that antigen-specific, non-cytotoxic murine lymphocyte clones express insulin receptors upon antigen exposure (Braciale et al. 1982 (Fauci et al. 1978) while an enhanced response was observed in rheumatoid arthritis (Tsoukas et al. 1980) (Marner et al. 1983 ). Many patients with IDDM of short duration also have signs of in¬ creased cellular hypersensitivity against pancreatic antigens (Nerup et al. 1971 ). Although the number of patients studied was limited we found that the IDDM patients with increased spontaneous immunoglobulin production had higher fasting C-peptide levels at the time of admission (Table 2) . In the 5 patients studied serially, one patient with increased immunoglobulin production at diagnosis developed lower C-peptide values while the other 4 remained unchanged. We also observed that the highest titres of islet cell cytoplasmic antibodies were detected in patients with spontaneous secre¬ tion. It is therefore less likely that the increased spontaneous secretion is simply explained by a lack of insulin which causes an altered immune re¬ sponse. An increased duration of IDDM is in fact known to be associated with a progressive loss of the ability of the endocrine pancreas to release C-peptide (Faber & Binder 1976 (Baekkeskov et al. 1982) . In Graves' disease and Hashimoto's thyroiditis the plaque forming cell assay has revealed thyroglobulin antibody pro¬ ducing cells particularly by thyroid-derived lym¬ phocytes (Weetman et al. 1982 
